NasdaqGM:VCELBiotechs
Vericel (VCEL) Q1 Loss Revives Valuation Concerns Despite Profitable Trailing Year
Vericel (VCEL) opened Q1 2026 with total revenue of US$68.4 million and a basic EPS loss of US$0.12, setting a clear focal point for how the market reads its latest update. Over recent periods the company has seen revenue move from US$52.6 million in Q1 2025 to US$68.4 million in Q1 2026, while basic EPS shifted from a loss of US$0.23 to a smaller loss of US$0.12, giving investors a clean read on how top line scale and earnings per share are tracking into this new quarter. Against that...